Informations:
Erreur:
ID
28487
Description
Duration of Platelet Inhibition by Aspirin; ODM derived from: https://clinicaltrials.gov/show/NCT00671021
Lien
https://clinicaltrials.gov/show/NCT00671021
Mots-clés
Versions (1)
- 17/01/2018 17/01/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
17 janvier 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Coronary Artery Disease NCT00671021
Eligibility Coronary Artery Disease NCT00671021
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT00671021
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Coronary Artery Disease Stable | Aspirin chronic
Item
patients suffering from stable cad, on chronic asa therapy
boolean
C1956346 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C0205360 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
Informed Consent
Item
patients willing to participate in the study and to sign the informed consent form
boolean
C0021430 (UMLS CUI [1])
Acute Coronary Syndrome | Revascularization
Item
acute coronary syndrome or revascularization in the last 3 months prior to enrolment
boolean
C0948089 (UMLS CUI [1])
C0581603 (UMLS CUI [2])
C0581603 (UMLS CUI [2])
Anti-Inflammatory Agents, Non-Steroidal | Cyclooxygenase 2 Inhibitors | clopidogrel | Ticlopidine | Dipyridamole | Warfarin | Acenocoumarol
Item
concurrent ingestion of nonsteroidal anti-inflammatory drugs (nsaids, including cox-2 selective anti-inflammatory drugs), clopidogrel, ticlopidine, dipyridamole, warfarin or acenocoumarol
boolean
C0003211 (UMLS CUI [1])
C1257954 (UMLS CUI [2])
C0070166 (UMLS CUI [3])
C0040207 (UMLS CUI [4])
C0012582 (UMLS CUI [5])
C0043031 (UMLS CUI [6])
C0000956 (UMLS CUI [7])
C1257954 (UMLS CUI [2])
C0070166 (UMLS CUI [3])
C0040207 (UMLS CUI [4])
C0012582 (UMLS CUI [5])
C0043031 (UMLS CUI [6])
C0000956 (UMLS CUI [7])
Non-Prescription NSAIDs times/week | Pharmaceutical Preparations Containing Aspirin times/week
Item
frequent use (more than once a week) of non-prescription nsaids or drugs containing asa in the 10 days preceding enrolment
boolean
C0013231 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C0456698 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C0004057 (UMLS CUI [2,3])
C0456698 (UMLS CUI [2,4])
C0003211 (UMLS CUI [1,2])
C0456698 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0332256 (UMLS CUI [2,2])
C0004057 (UMLS CUI [2,3])
C0456698 (UMLS CUI [2,4])
Major surgery
Item
major surgical procedure within 1 month before enrolment
boolean
C0679637 (UMLS CUI [1])
Bleeding tendency | Platelet dysfunction
Item
hemorrhagic diathesis or known platelet dysfunction
boolean
C1458140 (UMLS CUI [1])
C0679429 (UMLS CUI [2])
C0679429 (UMLS CUI [2])
Platelet count abnormal | Relationship Technical Problem
Item
platelet count outside the 100 to 450 x109/l range for technical reasons
boolean
C0580317 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C1710348 (UMLS CUI [2,2])
C0439849 (UMLS CUI [2,1])
C1710348 (UMLS CUI [2,2])
Hematocrit procedure | Hemoglobin measurement
Item
hematocrit < 25% or haemoglobin < 100 g/l
boolean
C0018935 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0518015 (UMLS CUI [2])
Dialysis Chronic Kidney Failure
Item
patient undergoing dialysis for chronic renal failure
boolean
C0011946 (UMLS CUI [1,1])
C0022661 (UMLS CUI [1,2])
C0022661 (UMLS CUI [1,2])
Patient Aspirin Resistant
Item
patient found to be asa resistant
boolean
C0030705 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C0332325 (UMLS CUI [1,3])
C0004057 (UMLS CUI [1,2])
C0332325 (UMLS CUI [1,3])